Back to clinical trials
RecruitingObservational
Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
NCT ID: NCT05480644Sponsor: Duke UniversityLast updated: 2025-11-19
Summary
The purpose of this protocol is to create a repository of blood samples from patients diagnosed with primary and metastatic brain tumors who are being seen in the Department of Radiation Oncology at Duke Cancer Center.
Detailed description
Repository blood samples will be used to study the association of circulating biomarkers with radiation therapy outcomes.
Outcome measures
Primary
Number of circulating immune cells in peripheral blood
reported as mean +/- standard deviation
Time frame: 6 weeks post radiation therapy
Eligibility criteria
Sex: AllAge: 18 Years and olderHealthy volunteers: No
Inclusion Criteria:
* Have a confirmed diagnosis of primary or metastatic brain tumor (histology or imaging as appropriate)
Exclusion Criteria:
* None
Study locations (1)
Duke Cancer Center
Durham, North Carolina, 27710
Eugene Vaios, MD MBA · Principal Investigator
Zach Reitman, MD PhD · Principal Investigator
Scott Flody, MD PhD · Principal Investigator